PRP in Mesa requires a drive to Chandler or Scottsdale

Dobson Road and Loop 202 lead many Mesa drivers toward Chandler

From west Mesa, Dobson Road runs south toward Chandler. Central Mesa drivers may use US-60, while Loop 202 Santan carries southeast Mesa drivers west toward Chandler. Your drive won't be the same in heavy traffic.

Old X-rays and medicine names may help the clinician. A few written questions can help you remember what matters. Tell the clinician which movement starts the ache, and you won't need anything more to begin the exam.

North Mesa may be closer to the Scottsdale office

From north and northeast Mesa, Loop 202 Red Mountain joins Loop 101 toward Scottsdale. The office is at 9220 E. Mountain View Road, Suite 210. Chandler isn't always the shorter drive from that area, and we want that detail to be clear.

The Chandler office is at 1100 S. Dobson Road, Suite 210, Chandler, AZ 85286. Neither office is inside Mesa. Both offices use (602) 837-PAIN, so you can ask which place has a time that suits you.

When soreness remains, nearby clinics can examine the joint

If the joint stays sore, regenerative treatment options are available from QC Kinetix. This means non-surgical care prepared there with material drawn from your blood. One choice is concentrated PRP, or platelet-rich plasma, made by spinning the blood and saving fluid with platelets for a syringe. Platelets help a cut clot and release early repair signals.

The clinicians known as medical providers review your health before discussing that care. They'll explain whether the exam supports it or points elsewhere. You can take notes or bring someone with you, and the choice remains yours.

Sources

1. Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.

   Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

2. The devices used to spin PRP at the point of care are cleared by FDA as clinical centrifuges, product code JQC, a Class I device under 21 CFR 862.2050 - for example the Biomet GPS Platelet Separation Kit (K030555, cleared 2003) and the Harvest SmartPrep2 / SmartPrep Platelet Concentration System (K103340, cleared 2010). That clearance covers the equipment that separates blood. It is not an FDA approval of platelet-rich plasma as a treatment for osteoarthritis, tendinopathy or any other orthopedic condition, and copy must never blur the two.

   U.S. Food and Drug Administration (Center for Devices and Radiological Health) — 510(k) Premarket Notification database and Product Classification: JQC, Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use, 21 CFR 862.2050. FDA accessdata (CDRH device databases), 2003.

3. The American Academy of Physical Medicine and Rehabilitation convened a technical expert panel that ran a structured literature review (2023, updated through June 2025) and a modified Delphi process, and issued five evidence-based clinical recommendations plus 11 consensus-based best practices for PRP in knee osteoarthritis. The statement is explicit that orthobiologic therapies 'remain an evolving area of practice' and that robust, dose-dependent randomized controlled trials are still needed to establish PRP's clinical effects.

   Borg-Stein J, Jayaram P, Colorado BS, et al. — AAPM&R guidance statement on platelet rich plasma for knee osteoarthritis. PM&R, 2026. DOI: 10.1002/pmrj.70144.